Effects on Cell Viability 639Chan GC, Hinds TR, Impey S, Storm DR (1998) Hippocampal neurotoxicity of∆9-tetra-
hydrocannabinol. J Neurosci 18:5322–5332
Chan PC, Sills RC, Braun AG, Haseman JK, Bucher JR (1996) Toxicity and carcinogenicity
of∆9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice. Fundam Appl Toxicol
30:109–117
Chen Y, Buck J (2000) Cannabinoids protect cells from oxidative cell death: a receptor
independent mechanism. J Pharmacol Exp Ther 293:807–812
DePetrocellisL,MelckD,PalmisanoA,BisognoT,LaezzaC,BifulcoM,DiMarzoV
(1998) The endogenous cannabinoid anandamide inhibits human breast cancer cell
proliferation. Proc Natl Acad Sci USA 95:8375–8380
Derkinderen P, Valjent E, Toutant M, Corvol JC, Enslen H, Ledent C, Trzaskos J, Caboche
J, Girault JA (2003) Regulation of extracellular signal-regulated kinase by cannabinoids
in hippocampus. J Neurosci 23:2371–2382
Derocq JM, Segui M, Marchand J, Le Fur G, Casellas P (1995) Cannabinoids enhance human
B-cell growth at low nanomolar concentrations. FEBS Lett 369:177–182
Derocq JM, Jbilo O, Bouaboula M, Ségui M, Clère C, Casellas P (2000) Genomic and func-
tional changes induced by the activation of the peripheral cannabinoid receptor CB2
in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell
differentiation. J Biol Chem 275:15621–15628
Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994)
Formationandinactivationofendogenouscannabinoidanandamideincentralneurons.
Nature 372:686–691
Downer EJ, Fogarty MP, Campbell VA (2003) TetraHydroCannabinol-induced neurotoxicity
depends on CB1 receptor mediated c-Jun N-terminal kinase activation in cultured
cortical neurons. Br J Pharmacol 140:547–557
Faubert Kaplan BL, Kaminski NE (2003) Cannabinoids inhibit the activation of ERK MAPK
in PMA/Io-stimulated mouse splenocytes. Int Immunopharmacol 3:1503–1510
Feigenbaum JJ, Bergmann F, Richmond SA, Mechoulam R, Nadler V, Kloog Y, Sokolovsky
M (1989) Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate re-
ceptor blocker. Proc Natl Acad Sci USA 86:9584–9587
FranklinA,Parmentier-BatteurS,WalterL,GreenbergDA,StellaN(2003)Palmitoylethanol-
amide increases after focal cerebral ischemia and potentiates microglial cell motility.
J Neurosci 23:7767–7775
Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic
signaling. Physiol Rev 83:1017–1066
Gallily R, Yamin A, Waksmann Y, Ovadia H, Weidenfeld J, Bar-Joseph A, Biegon A, Me-
choulam R, Shohami E (1997) Protection against septic shock and suppression of tumor
necrosis factorαand nitric oxide production by dexanabinol (HU-211), a nonpsy-
chotropic cannabinoid. J Pharmacol Exp Ther 283:918–924
Galve-Roperh I, Sánchez C, Cortés M, Gómez del Pulgar T, Izquierdo M, Guzmán M (2000)
Antitumoral action of cannabinoids: involvement of sustained ceramide accumulation
and extracellular signal-regulated kinase activation. Nat Med 6:313–319
Galve-Roperh I, Rueda D, Gómez del Pulgar MT, Velasco G, Guzmán M (2002) Mechanism
of extracellular signal-regulated kinase activation by the CB1 cannabinoid receptor. Mol
Pharmacol 62:1385–1392
Giuffrida A, Parsons LH, Kerr TM, Rodríguez de Fonseca F, Navarro M, Piomelli D (1999)
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat
Neurosci 2:358–363
Gómez del Pulgar T, Velasco G, Guzmán M (2000) The CB1 cannabinoid receptor is coupled
to the activation of protein kinase B/Akt. Biochem J 347:369–373
Gómez del Pulgar T, de Ceballos ML, Guzmán M, Velasco G (2002a) Cannabinoids pro-
tect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-
kinase/protein kinase B pathway. J Biol Chem 277:36527–36533
Gómez del Pulgar T, Velasco G, Sánchez C, Haro A, Guzmán M (2002b) De novo-synthesized
ceramide is involved in cannabinoid-induced apoptosis. Biochem J 363:183–188